by Igor Hajdukovic | Oct 12, 2026 | Uncategorized
Choosing a medical device for improving vaginal laxity by energy source alone can obscure the questions that matter most: what concern is being assessed, what evidence supports the proposed use, and what the device is authorized to do in Canada.Clinicians face a...
by Igor Hajdukovic | Oct 11, 2026 | Uncategorized
Symptom relief is not the same as anatomical correction. Non-surgical treatment for conjunctivochalasis may ease irritation, dryness, tearing, or a foreign-body sensation, but conservative care does not necessarily change loose conjunctival folds. These symptoms can...
by Igor Hajdukovic | Oct 10, 2026 | Uncategorized
A blepharitis treatment medical device should be assessed by its indication and evidence, not by how advanced its mechanism sounds. Blepharitis can present in different ways and overlap with meibomian gland dysfunction (MGD), so a device suited to one clinical target...
by Igor Hajdukovic | Oct 9, 2026 | Uncategorized
A plasma device for periocular rejuvenation should be assessed by more than its proposed cosmetic effect. Around the eyes, the treatment area, energy delivery and the device’s intended use all shape the clinical decision.Clinicians considering less invasive approaches...
by Igor Hajdukovic | Oct 8, 2026 | Uncategorized
A plasma therapy protocol can be clinically sound for one intervention and misleading for another. That distinction matters when developing a plasma therapy for meibomian gland dysfunction protocol: direct-current plasma devices and platelet-rich plasma (PRP) eye...
